Table 1. The risk factors, therapy, and anthropometric characteristics of the patients.
| Total (n = 78) | Male (n = 46) | Female (n = 32) | |
| Data were expressed as n (%) or mean ± SD. *P < 0.05. ACE: angiotensin-converting enzyme; ARB: angiotension II receptor blocker; eGFR: estimated glomerular filtration rate; LDL: low density lipoprotein. | |||
| Age | 66.0 ± 10.0 | 64.6 ± 10.9 | 68.1 ± 9.4 |
| Hypertension | 54 (69.2%) | 33 (71.7%) | 21 (65.6%) |
| Atrial fibrillation | 9 (11.5%) | 6 (13.0%) | 3 (9.4%) |
| Carotid atherosclerosis | 32 (41.0%) | 22 (47.8%) | 10 (31.3%) |
| Diabetes | 9 (11.5%) | 6 (13.0%) | 3 (9.4%) |
| Smoke | 22 (28.2%) | 17 (37.0%)* | 5 (15.6%)* |
| Number of risk factors | 2.3 ±1.4 | 2.6 ±1.5* | 1.8 ±1.3* |
| ASA | 23 (29.5%) | 14 (30.4%) | 9 (28.1%) |
| Statin | 10 (12.8%) | 8 (17.4%) | 2 (6.2%) |
| ACE/ARB | 30 (38.4%) | 21 (45.7%) | 9 (28.1%) |
| Betablockers | 34 (43.6%) | 20 (43.5%) | 14 (43.8%) |
| Diuretics | |||
| LDL | 124.8 ± 31.6 | 130.5 ± 32.1* | 116.8 ± 29.6* |
| eGFR | 74.3 ± 14.1 | 72.2 ± 15.2 | 77.3 ± 11.9 |